Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

Introduction: Phosphodiesterase type 5 inhibitors (PDE5i) are first-line therapy for most men with erectile dysfunction (ED). If ineffective, vacuum erection devices, intracavernous injections, and penile prosthesis implantation are suitable as second- or third-line therapies. However, very few pati...

Full description

Bibliographic Details

Published in:	Sexual Medicine
Main Authors:	Masato Shirai, MD, PhD, Ippei Hiramatsu, MD, Yusuke Aoki, MD, Hirofumi Shimoyama, MD, PhD, Taiki Mizuno, MD, PhD, Taiji Nozaki, MD, PhD, Shinichiro Fukuhara, MD, PhD, Atsushi Iwasa, MD, PhD, Shinji Kageyama, MD, PhD, Akira Tsujimura, MD, PhD
Format:	Article
Language:	English
Published:	Oxford University Press 2018-12-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2050116118300618